ENXTPA:IPHBiotechs
Innate Pharma (ENXTPA:IPH) Stock Price Trails Pipeline Progress As Losses Persist
Innate Pharma’s share price closed at €1.58 on Friday, leaving the stock lower over the past month while traders tried to make sense of a biotech story driven more by hope than current profit. The headline from these H1 2026 results is simple. Losses remain heavy, with net income excluding extra items at a loss of €19.6 million, yet the development portfolio and recent licensing deals mean sentiment is being pulled in two directions at once.
Love the drug pipeline potential at Innate Pharma...